| Title: |
A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels |
| Authors: |
Benboubker, L.; Valat, C.; Linassier, C.; Cartron, G.; Delain, M.; Bout, M.; Fetissof, F.; Lefranq, T.; Lamagnere, J. P.; Colombat, Ph. |
| Publisher Information: |
Oxford University Press |
| Publication Year: |
2000 |
| Collection: |
HighWire Press (Stanford University) |
| Subject Terms: |
Original articles |
| Description: |
Background Serum CA125 (sCA125) was recently reported to be of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma (NHL). This report aims to investigate the prognostic value of a new serologic index combining sCA125 and LDH serum levels. Patients and methods One hundred thirty-seven patients were studied, sixty-three with histologically proven low-grade NHL, and seventy-four with a high-grade subtype. Results sCA125 and LDH levels were elevated in more than one third of patients. sCA125 was more frequently increased than LDH in low-grade NHL. In this group, complete remission (CR) was achieved in 87, 45, and 0% ( P = |
| Document Type: |
text |
| File Description: |
text/html |
| Language: |
English |
| Relation: |
http://annonc.oxfordjournals.org/cgi/content/short/11/11/1485 |
| Availability: |
http://annonc.oxfordjournals.org/cgi/content/short/11/11/1485 |
| Rights: |
Copyright (C) 2000, European Society for Medical Oncology |
| Accession Number: |
edsbas.940A0652 |
| Database: |
BASE |